US Return Of GSK’s Blenrep Threatened By Ocular Toxicity, Dosage Optimization Questions

Blurred landscape
Blenrep's ocular adverse events include blurred vision and visual acuity changes. (Shutterstock)

More from US Advisory Committees

More from United States